According to a recent white paper summary issued by the American Clinical Laboratory Association (ACLA), when used appropriately, antibody testing may help determine the number of individuals who have been infected with SARS-CoV-2. By supporting screening for individuals using serology, healthcare professionals can provide a more detailed assessment regarding the true rate of infection and gain a better understanding of the case fatality rate to help inform public health strategies. Serologic testing also potentially could be used to support future vaccine development and contact tracing (the process of identification of persons who may have come into contact with an infected person and subsequent collection of further information about these contacts) to stop the spread of the infection in the community.